Professor Michael Parker's Great Australian Life
Join Laura Turner and her guest Professor Michael Parker. This program is proudly supported by Tobin Brothers Funerals - celebrating lives. Laura Turner catches up with an exciting world biochemistry and pharmacology expert working tirelessly to eradicate Alzheimer’s disease - Professor Michael Parker from the St. Vincent’s Institute of Medical Research. Michael and his team have just been awarded the Faye Williams Innovation Grant, worth $375,000, to further research into a new drug treatment with Alzheimer’s disease. With just under half a million Australians living with dementia, it is key and important work that could improve the lives of many. The research projects will show how acoustic sleep technology, paired with a new drug treatment may work to help reduce the toxins associated with the development and onset of Alzheimer’s disease. In Professor Parker’s research, there will be a new drug trialled that can help enhance the brain’s ability to clear the toxins associated with the development in Alzheimer’s disease. It is with this ground-breaking drug that there is new hope in delaying the onset of Alzheimer’s disease and removing previous negative consequences that came from some similar trials beforehand. This new experimental drug has shown positive preliminary breakthroughs in not only slowing down the onset and effects of Alzheimer’s disease, but may in fact reverse some of the effects of Alzheimer’s disease. Great Australian Lives is produced, engineered and edited by Jane Nield for SEN. Learn more about your ad choices. Visit megaphone.fm/adchoices